Stay updated on Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Sign up to get notified when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.

Latest updates to the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.7.2 instead of v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe site footer now identifies the revision as v3.7.1 instead of v3.7.0. The study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe study page now shows Revision: v3.7.0, indicating a site revision, and several older documents/metadata entries were removed from the study listing, reflecting housekeeping updates to the record.SummaryDifference21%

- Check55 days agoChange DetectedThe page now reflects a new software revision (v3.6.6) replacing the previous revision (v3.6.5). This indicates a small maintenance update to the site without substantive content changes to the study details.SummaryDifference0.1%

- Check76 days agoChange DetectedAn HTML error page is now shown, indicating the content is temporarily unavailable. This replaces the previously visible study record details and attachments with an error screen.SummaryDifference20%

- Check90 days agoChange DetectedThe site revision updated from v3.6.3 to v3.6.4, signaling a minor software update behind the pages with no visible changes to study details.SummaryDifference0.0%

Stay in the know with updates to Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reversing Therapy Resistance: Epigenetic-Immune Clinical Trial page.